SINGLETO2 THERAPEUTICS LLC
Superhydrophobic fiber optic photodynamic therapy device tip that delivers singlet oxygen to kill periodontal bacteria
- Sector
- Medtech
- Headquarters
- New Providence, NJ
- Total capital
- $3.8M
- Grants
- $3.8M
- 7 awards
- 7.0× sector median 1 award
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 1 granted · 3 pending
- 2.0× sector median 2 patents
Capital Timeline
Federal ↑Equity ↓201620172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Compliant Superhydrophobic Antimicrobial Photodynamic Therapy Bandage for the Prevention of Multidrug Resistant Wound Infections | $300,000 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Safe Disinfection and Oxygen-Level Enrichment in Recirculating Aquaculture Systems (RAS) Using Singlet Oxygen | $255,999 | |
| Federal grant | Department of Health and Human Services · Phase II · 3D-Printed Superhydrophobic-Tipped Optical Fiber for Targeted Periodontal Photodynamic Therapy | $754,377 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · 3D-Printed Superhydrophobic-Tipped Optical Fiber for Targeted Periodontal Photodynamic Therapy | $1,516,255 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · 3D-Printed Superhydrophobic-Tipped Optical Fiber for Targeted Periodontal Photodynamic Therapy | $761,878 | |
| Federal grant | Department of Health and Human Services · Phase I · Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic Therapy | $76,210 | |
| Federal grant | Department of Health and Human Services · Phase I · Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic Therapy | $148,507 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2289 | ETECTRX, INC. | — | — |
| 2290 | EDEN MEDICAL, INC. | — | — |
| 2291 | INTUITAP MEDICAL, INC. | — | — |
| 2292 | SINGLETO2 THERAPEUTICS LLC | — | — |
| 2293 | NANODIAGNOSTIC TECHNOLOGY, LLC | — | — |
| 2294 | POPNEURON LLC | — | — |
| 2295 | Paxos Medical Inc. | — | $2.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
No people are linked to this company yet.
People appear here when they are named as related persons in the company's own Form D filings. We don't infer people from social profiles.
Checked: SEC EDGAR Form D related persons through
Patents
- Singlet Oxygen Generating Device For Selective Destruction Of Pathogensapplication
- Singlet Oxygen Generating Device For Selective Destruction Of Pathogensgranted
- Singlet Oxygen Generating Device: Design Criteria To Optimize Singlet Oxygen Production And Water Purificationapplication
- Singlet Oxygen Generating Device For Selective Destruction Of Pathogensapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.